Medical Cannabis Related News
Freyherr International lists on a junior London stock market
A 200-year-old company has listed on a junior London stock market – raising over $5m for its growth into Europe.
Freyherr International plc is the...
Innovative technology development for cannabis safety
Following the relaxation of cannabis laws safety in the workplace and on the roads is of major concern.
Currently, the medical cannabis segment accounts for...
A turning tide: allowing access to medical cannabis
How Aurora Europe is helping establish the continents’ newest medical cannabis markets, could they help to improve access to medical cannabis?
Across Europe, a growing...
Plethora of medical cannabis applications is driving its legality worldwide
As the cannabis industry continues to develop, researchers are beginning to uncover additional benefits within the plant's biological content.
This is leading to a wide...
NOBL Group: a global leader in cannabis data & media
NOBL has assembled a leadership team of industry pioneers, innovators and experts combined with key leaders from dynamic fields, unlocking opportunities in the world...
New York cannabis legalisation efforts ramp up as industry shows potential
Earlier in July, New York state decriminalised the recreational use of marijuana. Instead of jail time, offenders will now be punished with a fine.
Governor Andrew Cuomo...
Tetra Bio-Pharma: global developer of cannabinoid-derived products
Dr Guy Chamberland explains how Tetra Bio-Pharma is taking a pharmaceutical pathway to discovering and developing cannabinoid-derived products.
In an industry that could aptly be...
Patients ditch their traditional medication in favour of cannabis
New data suggests many patients are ditching traditional medication prescriptions such as pain killers and switching to medical cannabis instead.
Prescription drugs range from depressants...
Symtomax: the medical cannabis company leading the field
Discover how the Porto based medical cannabis company, Symtomax, is poised to conquer the European market and beyond.
Symtomax based in Porto, Portugal are licenced...
The expansion of the study of cannabis opens new avenues to legalisation
Over a dozen countries have legalised cannabis for medicinal purposes while others have decriminalised it, allowing for moderate personal consumption.
As more countries have legalised...
Universities offer first cannabis certificate for healthcare professionals
Two educations institutions are offering their first cannabis certificate for healthcare professionals.
Pacific College of Oriental Medicine, a leader in integrative healthcare education, is the...
Limiting illicit cannabis trade as the industry continues expanding
Most regions around the world allow young adults at the age of 18 to enjoy or purchase their own alcohol and tobacco.
However, the US...
CBD use higher as nations across America relax cannabis restrictions
The US Drug Enforcement Agency recently announced plans to expand cannabis research after a prolonged delay.
The DEA said it hopes to receive a variety...
Europe could lose more ground in the medicinal cannabis industry
Europe is at risk of losing the market share to Africa in the medicinal cannabis industry, and Eco Equity have spotted the global potential.
There...
Health Europa Quarterly Issue 11
Health policy is in constant flux with healthcare models of every conceivable format facing growing pressure, here Health Europa Quarterly Issue 11 explores more.
Patients...
Medical cannabis knowledge sharing: can the UK learn from Australia?
Medical cannabis has been legal in Australia since 2016 with almost 20,000 legal patient approvals.
The law was introduced in Australia in February 2016 to...
Growing use as old cannabis stereotypes are debunked
Cannabis has been used for medicinal purposes for centuries, but despite the therapeutic benefits of the plant, international regulators ultimately deemed it unsafe for...
Sustainable future for cannabis: why Europe should prefer SmallCannabis™
Global cannabis prohibition is ending, and supply of legal cannabis is increasing. Here, Jim Plamondon of Thai Cannabis talks more about the sustainable future...
Zelda merger creates leading therapeutic medical cannabis company
Zelda Therapeutics Limited has announced a proposed merger of equals with Ilera Therapeutics LLC (Ilera Therapeutics).
Ilera Therapeutics is a privately held medical cannabis and...
Australian Government invests $3m for medical cannabis research
The Australian Government is investing AUD $3m (~€1.65m) from the Medical Research Future Fund (MRFF) into medical cannabis research.
The research is intended to examine...